Psychological interventions for co‐occurring depression and substance misuse
References
Additional references
Australian Bureau of Statistics. National Survey of Mental Health and Wellbeing: Summary of Results. Canberra: ABS, 2007.
Baker K, Lubman DI, Cosgrave EM, Killackey E, Yuen H, Hides L, et al. The impact of co‐occurring substance use on six‐month outcomes for young people seeking mental health treatment. Australian & New Zealand Journal of Psychiatry 2007;41:896‐902.
Bukstein O G, Glancy L G, Kaminer Y. Patterns of affective comorbidity in a clinical population of dually diagnosed adolescent substance users. Journal of the American Academy of Child & Adolescent Psychiatry 1992;31:1041‐5.
Degenhardt L Hall W, Lynskey M. Alcohol, cannabis and tobacco use among Australians: A comparison of their associations with other drug use and use disorders, affective and anxiety disorders, and psychosis. Addiction 2001;96(11):1603‐14.
Farrell M, Howes S, Bebbington P, Brugha T, Jenkins R, Lewis G, et al. Nicotine, alcohol and drug dependence and psychiatric comorbidity: Results of a national household survey. British Journal of Psychiatry 2001;179(5):432‐7.
Grant BF, Stinson FS, Dawson DA, Chou P, Dufour MC, Compton W, et al. Prevalence and co‐occurrence of substance use disorders and independent mood and anxiety disorderS. Archives of General Psychiatry 2004;61:807‐16.
Grella CE, Hser YI, Joshi V, Rounds‐Bryant J. Drug treatment outcomes for adolescents with comorbid mental and substance use disorders.. Journal of Nervous and Mental Disease 2001;189:384‐92.
Hasin DS, Liu X, Nunes E, McCloud S, Samet S, Endicott J. Effects of major depression on remission and relapse of substance dependence. Archives of General Psychiatry 2003;59:375‐80.
Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration Available from www.cochrane‐handbook.org.
Kessler RC, Berglund P, Demler OV, Jin R, Koretz D, Merikangas KE, et al. The Epidemiology of Major Depressive Disorder: Results From the National Comorbidity Survey Replication (NCS‐R). JAMA 2003;289:3095‐3105.
Lubman DI, Allen NB, Rogers N, Cementon E, Bonomo Y. The impact of co‐occurring mood and anxiety disorders among substance‐abusing youth.. Journal of Affective Disorders 2007;103:105‐12.
Pani PP, Vacca R, Trogu E, Amato L, Davoli M. Pharmacological treatment for depression during opioid agonist treatment for opioid dependence. Cochrane Database of Systematic Reviews 2010, Issue 9. [DOI: 10.1002/14651858.CD008373.pub2]
Sullivan LE, Fiellin DA, O'Connor P. The prevalence and impact of alcohol problem in major depression: A systematic review. The American Journal of Medicine 2005;118:330‐41.
Teesson M, Havard A, Fairbairn S, Ross J, Lynskey M, Darke S. Depression among entrants to treatment for heroin dependence in the Australian Treatment Outcome Study (ATOS): Prevalence, correlates and treatment seeking. Drug and Alcohol Dependence 2005;78:309‐15.
